A medical technology company focused on ear, nose, and throat treatments, best known for developing drug‑eluting implants used in sinus surgery to maintain sinus openings and deliver localized anti‑inflammatory medication. Its product portfolio targeted chronic sinusitis and postoperative care for E...
No congressional trades have been disclosed for Intersect ENT, Inc. (XENT) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.